bluebird bio, Inc. Analyst EPS Estimates
| Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
|---|---|---|---|---|
| Q1 2024 | 3 | -$0.55 | -$0.30 | -$0.44 |
| Q2 2024 | 4 | -$0.52 | -$0.28 | -$0.42 |
| Q3 2024 | 1 | -$0.45 | -$0.25 | -$0.36 |
| Q4 2024 | 2 | -$0.50 | -$0.15 | -$0.29 |
| Q1 2025 | 2 | -$0.28 | -$0.11 | -$0.18 |
| Q2 2025 | 1 | -$0.11 | -$0.06 | -$0.09 |
| Q3 2025 | 1 | -$0.02 | -$0.01 | -$0.02 |
| Q4 2025 | 1 | $0.01 | $0.01 | $0.01 |
| Q1 2026 | 1 | $0.02 | $0.04 | $0.03 |
| Q2 2026 | 1 | $0.03 | $0.06 | $0.05 |
| Q3 2026 | 1 | $0.05 | $0.09 | $0.07 |
| Q4 2026 | 1 | $0.06 | $0.11 | $0.09 |
bluebird bio, Inc. Earnings Date And Information
bluebird bio, Inc. last posted its earnings results on Friday, September 13th, 2024. The company reported $-0.78 earnings per share for the quarter, missing analysts' consensus estimates of $-0.61 by $0.17. The company had revenue of 10.61 M for the quarter and had revenue of 29.50 M for the year. bluebird bio, Inc. has generated $-2 earnings per share over the last year ($-1.93 diluted earnings per share) and currently has a price-to-earnings ratio of -0.21. bluebird bio, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based on prior year's report dates.
bluebird bio, Inc. Earnings History by Quarter
| Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
|---|---|---|---|---|---|---|
| 11/14/2024 | Q3 2024 | -$0.31 | $18.05 M | $10.61 M | ||
| 09/27/2024 | Q2 2024 | -$0.42 | $24.25 M | $16.10 M | ||
| 09/13/2024 | Q1 2024 | -$0.61 | -$0.36 | 0.25 | $18.57 M | |
| 09/13/2024 | Q4 2023 | -$0.61 | -$0.75 | -0.14 | $7.83 M | |
| 11/07/2023 | Q3 2023 | -$0.69 | -$0.66 | 0.03 | $13.56 M | $12.39 M |
| 08/08/2023 | Q2 2023 | -$0.72 | -$0.67 | 0.05 | $11.30 M | $6.89 M |
| 05/09/2023 | Q1 2023 | -$0.54 | $0.33 | 0.87 | $2.38 M | |
| 03/29/2023 | Q4 2022 | -$0.45 | $0.38 | 0.83 | $62,000 | |
| 11/07/2022 | Q3 2022 | -$1.28 | -$0.94 | 0.34 | $1.07 M | $71,000 |
| 08/04/2022 | Q2 2022 | -$1.31 | -$1.26 | 0.05 | $824,167 | $1.52 M |
| 05/09/2022 | Q1 2022 | -$1.26 | -$1.68 | -0.42 | $1.95 M | |
| 03/04/2022 | Q4 2021 | -$1.82 | -$2.14 | -0.32 | $1.61 M | |
| 11/05/2021 | Q3 2021 | -$2.72 | -$3.16 | -0.44 | $37.21 M | $22.68 M |
| 08/09/2021 | Q2 2021 | -$3.26 | -$3.58 | -0.32 | $16.28 M | $7.47 M |
| 05/05/2021 | Q1 2021 | -$3.05 | -$3.07 | -0.02 | $12.79 M | |
| 02/23/2021 | Q4 2020 | -$3.02 | -$3.01 | 0.01 | $10.71 M | |
| 11/04/2020 | Q3 2020 | -$3.07 | -$2.94 | 0.13 | $24.32 M | $19.27 M |
| 08/05/2020 | Q2 2020 | -$1.91 | -$0.36 | 1.55 | $76.46 M | $198.89 M |
| 05/11/2020 | Q1 2020 | -$3.94 | -$3.64 | 0.3 | $21.86 M | |
| 02/18/2020 | Q4 2019 | -$3.81 | -$4.04 | -0.23 | $10.00 M |
bluebird bio, Inc. Earnings: Frequently Asked Questions
-
When is bluebird bio, Inc.'s earnings date?
bluebird bio, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Tuesday, November 12th, 2024 based off last year's report dates.
-
How can I listen to bluebird bio, Inc.'s earnings conference call?
The conference call for bluebird bio, Inc.'s latest earnings report can be listened to online.
-
How can I read bluebird bio, Inc.'s conference call transcript?
The conference call transcript for bluebird bio, Inc.'s latest earnings report can be read online.
-
How much revenue does bluebird bio, Inc. generate each year?
bluebird bio, Inc. (:BLUE) has a recorded annual revenue of $29.50 M.
-
How much profit does bluebird bio, Inc. generate each year?
bluebird bio, Inc. (:BLUE) has a recorded net income of $29.50 M. bluebird bio, Inc. has generated $-1.93 earnings per share over the last four quarters.
-
What is bluebird bio, Inc.'s price-to-earnings ratio?
bluebird bio, Inc. (:BLUE) has a price-to-earnings ratio of -0.21 and price/earnings-to-growth ratio is -0.01.
